- Home
- GALT vs AACB Comparison
GALT vs AACB Comparison
Compare GALT & AACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.12
Company Overview
Basic Information| Metric | GALT | AACB |
|---|---|---|
| Founded | 2000 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 261.1M | 285.6M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | GALT | AACB |
|---|---|---|
| Price | $4.12 | $10.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 813.8K | 51.5K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $9.85 |
| 52 Week High | $7.13 | $10.34 |
Technical Indicators
Market Signals| Indicator | GALT | AACB |
|---|---|---|
| Relative Strength Index (RSI) | 36.28 | N/A |
| Support Level | $3.90 | N/A |
| Resistance Level | $4.19 | N/A |
| Average True Range (ATR) | 0.54 | 0.00 |
| MACD | -0.19 | 0.00 |
| Stochastic Oscillator | 17.22 | 0.00 |
Price Performance
Historical Comparison GALT
AACB
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About AACB Artius II Acquisition Inc. Class A Ordinary Shares
Artius II Acquisition Inc is a blank check company.